Neuroradiology:MRA上静脉窦高信号是什么?

2021-08-04 杨中华 脑血管病及重症文献导读

MRA上海绵窦高信号其实并不少见,大部分是反向静脉血流导致。

3D TOF MRA是一种无创性成像技术,广泛应用于各种脑血管疾病的MRI检查中。MRA还可用于筛查乙状窦(sigmoid sinus,SS)、横窦(transverse sinus,TS)、海绵窦(cavernous sinuses,CS)等的硬脑膜动静脉瘘(dural arteriovenous fistula,DAVF)。海绵窦DAVF的MRA特征通常指可见到静脉结构,如海绵窦、岩下窦(IPS)、岩上窦、翼丛(PP)、大脑中浅静脉、眼上静脉和蝶窦。

在3T MRA上经常可以看到逆向血流的高信号。先前的研究发现,在406名健康受试者中,43名(10.6%)受试者MRA的海绵窦上可见高信号。这些高信号被认为是翼丛/导静脉(EV)的反向血流信号,如来自颈内静脉(IJV)和乙状窦的反向血流。尽管以前的研究者描述了MRA海绵窦上偶见高信号的病理学和非病理学影像特征,但很难区分这个高信号是因为反向血流还是隐匿性海绵窦 DAVF。

图示1:翼丛(Pterygoid plexus,PP)/导静脉(Emissary vein,EV)的5点分级:I级=PP/EV的部分血流信号(箭头)高于背景信号,低于动脉信号;II级=PP/EV的部分血流信号(箭头)等于动脉信号;III级= 高信号(箭头)区域<=1/3海绵窦区域;IV级=高信号(箭头)区域>1/3海绵窦区域:

图片

图示2:岩下窦(Inferior petrosal sinus,IPS)和海绵窦(Cavernous sinuses,CS)的5点分级:I级=部分IPS的血流信号(箭头)高于背景信号,低于动脉信号;Ⅱ级=部分IPS的血流信号(箭头)等于动脉信号;III级=高信号(箭头)区域<=1/3海绵窦区域;IV级=高信号(箭头)区域>1/3海绵窦区域:

 

图片

示例1:72岁,男性,PP/EV 分级为 IV 级。MRA 原始图像(a)和 MIP(b)显示左侧 PP/EV 和海绵窦高信号(箭头)。ASL(c)未见PP/EV 和海绵窦高信号(箭头)。DSA 未见海绵窦 DAVF(d):

 

图片
图片

示例2:72岁,男性,无 DAVF。MRA 原始图像(a,b)和 MIP(c)可见左侧横窦和颈内静脉(箭头)高信号。ASL 显示左侧横窦和颈内静脉(箭头)高信号。这种高信号来源于反向血流(译者注:不是 DAVF,未提供 DSA):

 

图片
图片

 

示例3:67岁,男性,右侧海绵窦 DAVF(Cognard I)。MRA 原始图像(a)显示右侧海绵窦轻微升高的信号(箭头)。ASL(b)显示右侧海绵窦高信号(箭头)。DSA 显示右侧海绵窦 DAVF(c):

 

图片
图片

2021年6月来自日本的Shingo Kakeda等在Neuroradiology上报道了364例(728侧)无动静脉分流患者的 MRA,在 MRA 上发现99侧(13.6%)可见海绵窦反向血流高信号,而没有一例的 ASL 表现高信号。在这些病例中,3侧乙状窦、3侧横窦和8侧颈内静脉高信号。所有这些MRA上静脉窦的高信号都是因为反向血流。

最终作者认为,对于鉴别反向静脉血流和海绵窦 DAVF,ASL 是一种简便易行和有用处的 MRI 序列。对于乙状窦和横窦,由于来自于颈静脉的反向血流,ASL 会产生假阳性的结果,这是 ASL 的局限性,影像学专家应该警惕这种 ASL 的局限性。

译者注:这篇文章的意思是说,MRA 上海绵窦高信号不少见,大部分都是因为反向静脉血流所致。如果 ASL 阴性(绝大部分都是 ASL 阴性),提示反向血流;如果 ASL 阳性可能是由于反向血流所致,也可能是 DAVF。

文献出处: Neuroradiology. 2021 Jun;63(6):889-896. doi: 10.1007/s00234-020-02588-5. Epub 2020 Oct 21. High-signal venous sinuses on MR angiography: discrimination between reversal of venous flow and arteriovenous shunting using arterial spin labeling

图文来源|脑血管病及重症文献导读

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1698246, encodeId=919c169824626, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Thu Nov 18 10:23:46 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950834, encodeId=c0f219508349a, content=<a href='/topic/show?id=20101021e97e' target=_blank style='color:#2F92EE;'>#高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102179, encryptionId=20101021e97e, topicName=高信号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Tue Apr 19 06:23:46 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595596, encodeId=b6391595596ae, content=<a href='/topic/show?id=8d8412188c4' target=_blank style='color:#2F92EE;'>#MRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12188, encryptionId=8d8412188c4, topicName=MRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3bd18274454, createdName=FukaiBao, createdTime=Fri Aug 06 06:23:46 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618561, encodeId=f27716185610a, content=<a href='/topic/show?id=a95e9916698' target=_blank style='color:#2F92EE;'>#静脉窦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99166, encryptionId=a95e9916698, topicName=静脉窦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=237819898930, createdName=12498d2fm57(暂无昵称), createdTime=Fri Aug 06 06:23:46 CST 2021, time=2021-08-06, status=1, ipAttribution=)]
    2021-11-18 fusion
  2. [GetPortalCommentsPageByObjectIdResponse(id=1698246, encodeId=919c169824626, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Thu Nov 18 10:23:46 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950834, encodeId=c0f219508349a, content=<a href='/topic/show?id=20101021e97e' target=_blank style='color:#2F92EE;'>#高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102179, encryptionId=20101021e97e, topicName=高信号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Tue Apr 19 06:23:46 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595596, encodeId=b6391595596ae, content=<a href='/topic/show?id=8d8412188c4' target=_blank style='color:#2F92EE;'>#MRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12188, encryptionId=8d8412188c4, topicName=MRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3bd18274454, createdName=FukaiBao, createdTime=Fri Aug 06 06:23:46 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618561, encodeId=f27716185610a, content=<a href='/topic/show?id=a95e9916698' target=_blank style='color:#2F92EE;'>#静脉窦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99166, encryptionId=a95e9916698, topicName=静脉窦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=237819898930, createdName=12498d2fm57(暂无昵称), createdTime=Fri Aug 06 06:23:46 CST 2021, time=2021-08-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1698246, encodeId=919c169824626, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Thu Nov 18 10:23:46 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950834, encodeId=c0f219508349a, content=<a href='/topic/show?id=20101021e97e' target=_blank style='color:#2F92EE;'>#高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102179, encryptionId=20101021e97e, topicName=高信号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Tue Apr 19 06:23:46 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595596, encodeId=b6391595596ae, content=<a href='/topic/show?id=8d8412188c4' target=_blank style='color:#2F92EE;'>#MRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12188, encryptionId=8d8412188c4, topicName=MRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3bd18274454, createdName=FukaiBao, createdTime=Fri Aug 06 06:23:46 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618561, encodeId=f27716185610a, content=<a href='/topic/show?id=a95e9916698' target=_blank style='color:#2F92EE;'>#静脉窦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99166, encryptionId=a95e9916698, topicName=静脉窦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=237819898930, createdName=12498d2fm57(暂无昵称), createdTime=Fri Aug 06 06:23:46 CST 2021, time=2021-08-06, status=1, ipAttribution=)]
    2021-08-06 FukaiBao
  4. [GetPortalCommentsPageByObjectIdResponse(id=1698246, encodeId=919c169824626, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Thu Nov 18 10:23:46 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950834, encodeId=c0f219508349a, content=<a href='/topic/show?id=20101021e97e' target=_blank style='color:#2F92EE;'>#高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102179, encryptionId=20101021e97e, topicName=高信号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Tue Apr 19 06:23:46 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595596, encodeId=b6391595596ae, content=<a href='/topic/show?id=8d8412188c4' target=_blank style='color:#2F92EE;'>#MRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12188, encryptionId=8d8412188c4, topicName=MRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3bd18274454, createdName=FukaiBao, createdTime=Fri Aug 06 06:23:46 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618561, encodeId=f27716185610a, content=<a href='/topic/show?id=a95e9916698' target=_blank style='color:#2F92EE;'>#静脉窦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99166, encryptionId=a95e9916698, topicName=静脉窦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=237819898930, createdName=12498d2fm57(暂无昵称), createdTime=Fri Aug 06 06:23:46 CST 2021, time=2021-08-06, status=1, ipAttribution=)]

相关资讯

Am J Neuroradiol:探究TOF MRA与DSA在成人原发性中枢神经系统血管炎中价值的一致性。

原发性中枢神经系统血管炎可发生于任何年龄,既往身体多健康。平均发病年龄在40多岁(3~74岁),男女均可发病,男性略多。约60%的患者呈急性或亚急性起病,但有些患者可呈缓慢进展的智能衰退,以及局灶性神经损害的病程,在疾病的早期症状可自行缓解。3D TOF MRA和DSA是现有检查原发性中枢神经系统血管炎累及血管的技术。本研究比较血管造影3D TOF MRA和DSA在诊断原发性中枢神经系统血管炎的诊

Radiology:锰与钆的对决--谁才是MR对比剂王座的主人?

本研究旨在比较锰磁共振(MR)对比剂Mn-PyC3A与钆MR对比剂Gd-DTPA的血管内强化效果,评价Mn-PyC3A的排泄、药物动力学参数和代谢,并将结果发表在Radiology上。

Radiology:对于急性前循环缺血性卒中患者,影像学又有了新的评估手段!

当大血管闭塞导致脑缺血时,细胞活力取决于侧支循环的灌注状态。研究表明,大缺血核心合并侧支循环不良是血管内治疗不良反应和功能预后不良的强有力预测因子。

JAMA Neurol:3mm及以下的偶发微小未破裂动脉瘤患者的临床管理

研究认为,对于3mm及以下的偶发微小未破裂动脉瘤,非预防性治疗或影像随访是最有效的策略

Neuroradiology:MRA 和 SWI 诊断高灌注

示例一,6周女孩,新发痫性发作和呼吸暂停24h。

Radiology:利用MR AccASL技术评估Moyamoya病其显示远端脑动脉及侧枝循环的的价值

目的:以DSA诊断作为金标,评估和比较AccASL-MRA和TOF-MRA两种成像方式在Moyamoya病中对脑动脉及侧枝循环显示的价值,并将结果发表在Radiology上。

拓展阅读

European Radiology:应用SS MRA评估股骨头坏死血供变化的价值

稳态 (SS) 磁共振血管造影 (MRA)作为一种具有良好的血液和组织对比度的无创成像方式,在过去的几年中显示出巨大的前景。

影像解剖 | 大脑中动脉分段及MRA(值得收藏!)

大脑中动脉从颈内动脉分叉起,水平外行抵达前床突附近的外侧裂窝止,称为水平段。在正位片上显示为由内向外水平走向,故称水平段,长约14 —16 m m。

Investigative Radiology:减少造影剂剂量对胸腹动态三维MRA中血管增强和图像质量的影响

在常规的临床实践中,静态和动态的3D-MRAs经常被结合起来应用以便对血管进行高空间(解剖)和时间(动态)分辨率的检查。

European Radiology:如何实现低剂量MRA的动静脉畸形显影?

现阶段,使用钆剂(GBCA)的动态增强磁共振血管成像已被认为是替代DSA的一种无创成像方法。

European Radiology:1.5T和3T非增强MR血管造影显示子宫和卵巢动脉的比较

三维(3D)盆腔磁共振血管成像(MRA)为介入放射科医生提供了十分有价值的解剖信息,现已常规应用于子宫动脉栓塞术(UAE)的术前评估,为术前术式的选择和风险的评估提供了影像学支持。

心电图or颅脑MRA?更能找出预后不良的癌症合并卒中患者?

PLOS ONE:颅内动脉粥样硬化和心房颤动对活动性癌症患者缺血性中风的预后的影响